Equillium, Inc.·4

Mar 11, 8:11 PM ET

Zedelmayer Christine 4

Research Summary

AI-generated summary

Updated

Equillium (EQ) COO Christine Zedelmayer Exercises Options, Sells Shares

What Happened

  • Christine Zedelmayer, Senior Vice President and COO of Equillium (EQ), exercised a total of 152,361 option shares on March 9, 2026 (three exercises at $0.79 each, aggregate cost $119,604) and sold 181,219 common shares in open-market transactions the same day for approximately $362,438 (weighted avg price $2.00). The filing also shows corresponding derivative disposals at $0.00 reflecting the conversion/retirement of the exercised option instruments.

Key Details

  • Transaction date: March 9, 2026; Form 4 filed March 11, 2026 (timely).
  • Options exercised: 35,695 + 41,666 + 75,000 = 152,361 shares at $0.79; total cash paid ≈ $119,604.
  • Open-market sale: 181,219 shares, weighted average price $2.00 (sales executed between $2.00 and $2.015 per share); total proceeds ≈ $362,438.
  • Footnote F1: Sales were made under a Rule 10b5-1 trading plan adopted Aug 27, 2025.
  • Footnote F2: Price shown is weighted average; trades occurred at $2.00–$2.015.
  • Footnote F3: The option vesting schedule: 25% after one year, then monthly over 3 years (applies to the option grant).
  • Shares owned after the transaction: not disclosed in the supplied filing details.

Context

  • This was an option exercise followed by an immediate open-market sale of shares (consistent with a cashless or sell-to-cover pattern). The sale was executed under a pre-established 10b5-1 plan, which indicates the trades were pre-planned rather than ad-hoc. The filing is factual and does not indicate insider intent.